Company |
Drug |
Indication |
Celgene Corp. |
Abraxane |
Non-small-cell lung cancer |
Genentech Inc. |
Actemra |
Rheumatoid arthritis |
NextWave Pharmaceuticals Inc. |
Quillivant XR |
Attention deficit hyperactivity disorder |
Nuvo Research Inc. |
Pliaglis |
Dermatological conditions |
Teva Pharmaceuticals Industries |
Synribo |
Chronic myelogenous leukemia |
ThromboGenics NV |
Jetrea |
Symptomatic vitreomacular adhesion |